Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 33 No. 21, May 25, 2007 issue of the Florida Administrative Weekly.

The change is in response to written comments submitted by the staff of the Joint Administrative Procedures Committee. The rule shall now read as follows:

64B16-26.600 Tripartite Continuing Education Committee.

(1) The Tripartite Continuing Education Committee will be composed of equal representation from the Board of Pharmacy, each College or School of Pharmacy in the State, and practicing pharmacists within the State. The members of the Committee shall be selected by the Board of Pharmacy and serve for a period of two years. The chairman of the Committee shall be selected by the Chair of the Board.

(2) The Tripartite Continuing Education Committee shall perform the following duties pursuant to Rule 64B16-26.601, F.A.C.:

(a) Review continuing education providers and make recommendations to the Board;

(b) Approve continuing education course or program for approved providers or individuals that are non-approved providers for the following:

1. General

2. Initial Consultant Pharmacist Certification

3. Consultant Recertification;

4. Nuclear Recertification;

5. Medication Errors;

6. HIV/AIDS;

7. Laboratory Tests;

8. Laws and Rules;

9. Quality Related Events.

(3) The Tripartite Continuing Education Committee shall perform auditing and monitoring activities pursuant to Rule 64B16-26.601, F.A.C. The Tripartite Committee shall perform an audit on each approved continuing education provider 90 days prior to the end of the biennium. The approved provider shall submit the following information for one program of the provider’s choosing and one program selected by the Board:

(a) Title, date and location of the program;

(b) Program Number;

(d) Total number of pharmacists attending;

(e) Rosters of attendees with appropriate license numbers;

(f) Brochures of program announcement;

(g) CV’s of each speaker;

(h) Handouts, Copy of CE Credit statement, educational materials distributed as part of the program; and

(i) Summary report of program evaluations.

(4) The Committee shall hold meetings as may be convened at the call of the Chairman of the Committee.

Specific Authority 465.005, 465.009(5) FS. Law Implemented 465.009 FS. History–New 10-18-79, Amended 7-29-81, Formerly 21S-13.01, 21S-13.001, 21S-26.600, 61F10-26.600, 59X-26.600, Amended 10-15-01, 3-10-05, .

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca Poston, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254